Paragraph
@paragraph
Clinical studies on Alzheimer's treatment Lecanemab in Japan reveal minimal cognitive improvement compared to placebo, with numerous dropouts and reports of serious side effects like brain edema and cerebral hemorrhage. Concerns also exist regarding transparency in the clinical trial process. @bycomet
0 reply
0 recast
0 reaction